Moreover, the epidermal growth factor/Erb-B2 receptor tyrosine kinase 2 (EGF/ERBB2) signaling pathway in breast cancer cells modulated the transcription activity of ESRRA, which was associated with poor prognosis in breast and ovarian cancers32,34,35. Here, EGF is linked to breast carcinoma.